Introduction
In this in-depth article for Cipla Ltd (NSE: CIPLA) share price, we bring you the latest live price, key financial metrics, recent analyst commentary and what this means for investors. On the platform of Vizzve Finance, we aim to deliver timely insights that can be quickly indexed and surface in Google trends thanks to thorough SEO optimisation.
Latest Share Price Snapshot
As of the latest available data:
The share price of Cipla is around ₹1,583.90 on 29 October 2025 at ~11:13 AM IST.
On 24 October 2025, the price was ~₹1,583.75 showing a drop of ~3.74% that day.
Recent live value on another platform: ~₹1,581.10.
Key price levels:
52-week high: ~₹1,672.20 (23 Oct 2025)
52-week low: ~₹1,310.05 (07 Apr 2025)
Key Financial & Valuation Metrics
Here are some of the important ratios and data points that investors often track:
Market capitalization: ~₹1,27,940 cr as per data on 29 October 2025.
P/E ratio (approx): ~23-24x depending on source.
Dividend yield: ~1.0% area.
These metrics suggest that while Cipla is not cheaply valued, it commands a reasonable premium — typical for a large-cap pharmaceutical company with diversified operations.
What’s Driving the Price Movement?
Internal factors
Strong earnings: For example, in Q4 FY25, Cipla reported robust growth in net profit and revenues.
Regulatory and operational progress: The company’s filings suggest it is positioned for growth in new markets and treatments.
External factors
Pharma sector sentiment: Regulatory, export and currency considerations impact pharmaceutical stocks.
Broader market trends: Investors rotate in/out of large-cap defensive stocks like pharma depending on macro outlook.
Analyst Outlook & Target Prices
Some analysts have provided 12-month target price for Cipla at ~₹1,785 indicating upside from the current level.
Earlier reports had a target near ~₹1,653 with expected upside ~9% from ~₹1,512.
Vizzve Finance Recommendation & Trend-Indexing Strategy
At Vizzve Finance, we recommend:
Marking this article for frequent updates (live price, material events) so Google sees “freshness” and indexes quickly.
Using structured data (schema markup) for stock price and company, plus optimised headings (H1, H2) with the keyword “Cipla share price”.
Publishing around market open times (India) so that traffic spikes can trigger Google indexing and trending behaviour.
Encouraging internal linking to other pharma company analyses to build topical authority.
Risk Factors to Keep in Mind
Regulatory risk: As with all pharma companies, inspections, approvals and regulatory compliance can impact performance.
Competitive pressures: Generic drug competition, pricing pressures and margin squeeze are persistent.
Currency and export exposure: Given global operations, foreign-exchange movements and export regulation can affect earnings.
Valuation risk: With current valuations, significant upside is not guaranteed unless growth accelerates.
FAQ Section
Q1. What is the current share price of Cipla?
A: As of 29 October 2025, the share price is ~₹1,583.90 on NSE.
Q2. What has been Cipla’s 52-week performance?
A: The 52-week high is ~₹1,672.20, and the 52-week low is ~₹1,310.05.
Q3. What is the P/E ratio of Cipla currently?
A: P/E is approximately ~23-24x, per recent sources.
Q4. Is Cipla a good buy right now?
A: That depends on your investment horizon, risk tolerance and views on the pharma sector. The company has solid fundamentals but isn’t priced at a deep discount, so upside depends on further growth catalysts.
Q5. How often should I monitor Cipla’s share price and updates?
A: For long-term investors, monitoring quarterly results and major regulatory/market events may suffice. Traders may want shorter-term updates. At Vizzve Finance, we recommend setting alerts for major earnings or regulatory changes.
Published on : 30th October
Published by : Deepa R
www.vizzve.com || www.vizzveservices.com
Follow us on social media: Facebook || Linkedin || Instagram
🛡 Powered by Vizzve Financial
RBI-Registered Loan Partner | 10 Lakh+ Customers | ₹600 Cr+ Disbursed